- Home
- BWLP vs VERA Comparison
BWLP vs VERA Comparison
Compare BWLP & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- VERA
- Stock Information
- Founded
- BWLP 1935
- VERA 2016
- Country
- BWLP Singapore
- VERA United States
- Employees
- BWLP N/A
- VERA N/A
- Industry
- BWLP Marine Transportation
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- BWLP Consumer Discretionary
- VERA Health Care
- Exchange
- BWLP Nasdaq
- VERA Nasdaq
- Market Cap
- BWLP 1.9B
- VERA 2.5B
- IPO Year
- BWLP N/A
- VERA 2021
- Fundamental
- Price
- BWLP $12.76
- VERA $42.01
- Analyst Decision
- BWLP
- VERA Strong Buy
- Analyst Count
- BWLP 0
- VERA 9
- Target Price
- BWLP N/A
- VERA $53.56
- AVG Volume (30 Days)
- BWLP 255.5K
- VERA 683.6K
- Earning Date
- BWLP 01-01-0001
- VERA 11-07-2024
- Dividend Yield
- BWLP 24.68%
- VERA N/A
- EPS Growth
- BWLP 43.64
- VERA N/A
- EPS
- BWLP 3.64
- VERA N/A
- Revenue
- BWLP $3,510,244,000.00
- VERA N/A
- Revenue This Year
- BWLP N/A
- VERA N/A
- Revenue Next Year
- BWLP N/A
- VERA N/A
- P/E Ratio
- BWLP $3.68
- VERA N/A
- Revenue Growth
- BWLP 57.96
- VERA N/A
- 52 Week Low
- BWLP $10.32
- VERA $9.68
- 52 Week High
- BWLP $22.31
- VERA $50.78
- Technical
- Relative Strength Index (RSI)
- BWLP 33.59
- VERA 52.57
- Support Level
- BWLP $13.21
- VERA $39.22
- Resistance Level
- BWLP $13.58
- VERA $50.00
- Average True Range (ATR)
- BWLP 0.23
- VERA 2.41
- MACD
- BWLP -0.15
- VERA 0.24
- Stochastic Oscillator
- BWLP 2.94
- VERA 28.53
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.